GeneCellNano

Gene Cell Nano

GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.

University of Eastern Finland to participate in European alliance for rare disease research23.9.2024
Honorary doctorate awarded to Marjo Yliperttula19.6.2024
Honorary doctorate awarded to Seppo Ylä-Herttuala30.5.2024
Third ERC Grant for Professor Olli Ikkala12.4.2024
Save the Date for the Third Annual Meeting!7.12.2023

More News

Events

GeneCellNano Roadshow 202423.9.2024
17th Annual Meeting of the Finnish Atherosclerosis Society 10.-11.6.202423.4.2024
The 3rd Annual GCN Meeting 18.-19.4.202413.3.2024
EV4US & FISEV Annual meeting: extracellular vesicle research days in Oulu 5.-6.2.202415.1.2024
AIX Forum: collaborative meeting between GeneCellNano and the FCAI Flagship7.12.2023

More Events

GeneCellNano is an interdisciplinary community of top experts specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechniques linked with their management.

Gene Cell Nano

News

Events